Trestolone acetate: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|Synthetic anabolic-androgenic steroid}} | |||
{{Use dmy dates|date=October 2023}} | |||
'''Trestolone acetate''', also known as '''7_-methyl-19-nortestosterone 17_-acetate''' (MENT), is a synthetic [[anabolic-androgenic steroid]] (AAS) and a derivative of [[nandrolone]]. It is primarily used in scientific research and has been investigated for potential applications in [[male contraception]] and [[hormone replacement therapy]]. | |||
Trestolone acetate, as | |||
==Chemical structure and properties== | |||
Trestolone acetate is a [[nandrolone]] derivative, characterized by the presence of a methyl group at the 7_ position. This modification enhances its [[androgenic]] and [[anabolic]] activity compared to nandrolone. The acetate ester attached to the 17_-hydroxyl group prolongs its duration of action by slowing its release into the bloodstream. | |||
==Pharmacology== | ==Pharmacology== | ||
Trestolone acetate acts as a potent agonist of the [[androgen receptor]] (AR), which mediates its anabolic and androgenic effects. It has been shown to have a high binding affinity for the AR, leading to significant increases in muscle mass and strength. Unlike [[testosterone]], trestolone acetate does not undergo conversion to [[dihydrotestosterone]] (DHT), which may reduce the risk of certain androgenic side effects. | |||
==Potential applications== | |||
===Male contraception=== | |||
Trestolone acetate has been studied as a potential [[male contraceptive]] due to its ability to suppress [[spermatogenesis]] while maintaining [[libido]] and other androgen-dependent functions. Clinical trials have explored its efficacy in combination with other hormones, such as [[progestins]], to achieve effective contraception. | |||
== | ===Hormone replacement therapy=== | ||
In [[hormone replacement therapy]] for men with [[hypogonadism]], trestolone acetate may offer advantages over traditional testosterone therapy. Its potent anabolic effects and lack of conversion to DHT make it a promising candidate for maintaining muscle mass and bone density. | |||
==Side effects== | ==Side effects== | ||
As with other AAS, trestolone acetate can cause a range of side effects, including [[acne]], [[gynecomastia]], and [[cardiovascular]] issues. Long-term use may also lead to [[liver damage]] and alterations in [[lipid profiles]]. | |||
==Legal status== | |||
The legal status of trestolone acetate varies by country. In some regions, it is classified as a controlled substance, while in others, it is available for research purposes only. | |||
== | ==Related pages== | ||
* [[Anabolic steroid]] | * [[Anabolic steroid]] | ||
* [[ | * [[Nandrolone]] | ||
* [[Testosterone]] | |||
* [[Male contraception]] | * [[Male contraception]] | ||
==References== | ==References== | ||
{{Reflist}} | |||
[[Category:Anabolic steroids]] | [[Category:Anabolic steroids]] | ||
[[Category:Androgens]] | [[Category:Androgens and anabolic steroids]] | ||
[[Category: | [[Category:Hormonal contraception]] | ||
[[Category: | [[Category:Experimental drugs]] | ||
[[File:Trestolone_acetate.svg|thumb|Chemical structure of trestolone acetate]] | |||
Revision as of 15:47, 9 February 2025
Synthetic anabolic-androgenic steroid
Trestolone acetate, also known as 7_-methyl-19-nortestosterone 17_-acetate (MENT), is a synthetic anabolic-androgenic steroid (AAS) and a derivative of nandrolone. It is primarily used in scientific research and has been investigated for potential applications in male contraception and hormone replacement therapy.
Chemical structure and properties
Trestolone acetate is a nandrolone derivative, characterized by the presence of a methyl group at the 7_ position. This modification enhances its androgenic and anabolic activity compared to nandrolone. The acetate ester attached to the 17_-hydroxyl group prolongs its duration of action by slowing its release into the bloodstream.
Pharmacology
Trestolone acetate acts as a potent agonist of the androgen receptor (AR), which mediates its anabolic and androgenic effects. It has been shown to have a high binding affinity for the AR, leading to significant increases in muscle mass and strength. Unlike testosterone, trestolone acetate does not undergo conversion to dihydrotestosterone (DHT), which may reduce the risk of certain androgenic side effects.
Potential applications
Male contraception
Trestolone acetate has been studied as a potential male contraceptive due to its ability to suppress spermatogenesis while maintaining libido and other androgen-dependent functions. Clinical trials have explored its efficacy in combination with other hormones, such as progestins, to achieve effective contraception.
Hormone replacement therapy
In hormone replacement therapy for men with hypogonadism, trestolone acetate may offer advantages over traditional testosterone therapy. Its potent anabolic effects and lack of conversion to DHT make it a promising candidate for maintaining muscle mass and bone density.
Side effects
As with other AAS, trestolone acetate can cause a range of side effects, including acne, gynecomastia, and cardiovascular issues. Long-term use may also lead to liver damage and alterations in lipid profiles.
Legal status
The legal status of trestolone acetate varies by country. In some regions, it is classified as a controlled substance, while in others, it is available for research purposes only.
Related pages
References
<references group="" responsive="1"></references>
